Chosa Oncology AB operates as a biotechnology company, which focuses on developing drugs related to cancer treatment. Its products include iCIP, LiPlaCis and DRP. The company was founded on January 11, 2023 and is headquartered in Lund, Sweden.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange CHOSA ONCOLOGY stocks are traded under the ticker W5L.
W5L reached its all-time high on May 13, 2024 with the price of 0.0960 EUR, and its all-time low was 0.0180 EUR and was reached on Feb 23, 2024. View more price dynamics on W5L chart. See other stocks reaching their highest and lowest prices.
W5L net income for the last quarter is −164.06 K EUR, while the quarter before that showed −170.95 K EUR of net income which accounts for 4.03% change. Track more CHOSA ONCOLOGY financial stats to get the full picture.
No, W5L doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, W5L shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CHOSA ONCOLOGY stock right from TradingView charts — choose your broker and connect to your account.